[Federal Register Volume 71, Number 215 (Tuesday, November 7, 2006)]
[Rules and Regulations]
[Pages 65052-65053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-18679]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522


Implantation or Injectable Dosage Form New Animal Drugs; 
Lincomycin; Correction

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Final rule; correction.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is correcting a 
document amending the animal drug regulations to reflect approval of an 
abbreviated new animal drug application (ANADA) that appeared in the 
Federal Register of September 1, 2006 (71 FR 51995). FDA is correcting 
the date of approval of an ANADA for a generic lincomycin injectable 
solution which was drafted in error. This correction is being made to 
improve the accuracy of the Federal Register.

DATES:  This rule is effective November 7, 2006.

FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for 
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 
Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: 
[email protected].



[[Page 65053]]

SUPPLEMENTARY INFORMATION:
    In FR Doc. E6-14509, appearing on page 51995 in the Federal 
Register of September 1, 2006, the following correction is made:
    1. On page 51995, in the third column, in the third sentence of the 
SUPPLEMENTARY INFORMATION section, the date of ANADA approval ``July 
27, 2006'' is corrected to read ``August 2, 2006''.

    Dated: October 20, 2006.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. E6-18679 Filed 11-6-06; 8:45 am]
BILLING CODE 4160-01-S